Background Epidemiological studies have shown that chronic kidney disease (CKD) is an
important risk factor for atherosclerosis and cardiovascular disease (CAD). The aim of the …

Background The prevalence of chronic kidney disease is rising continuously.
Cardiovascular disease is among leading causes of death and premature mortality of …

Aim We aimed to investigate the factors affecting the development of atherosclerosis and the
role of calcification inhibitors fetuin-A, matrix-Gla protein (MGP), osteoprotegerin (OPG) in …

Background/aim: Fetuin-A, a circulating inhibitor of calcification, is a marker of inflammatory-
nutritional state. We evaluated the association between serum fetuin-A levels and vascular …

Aims: Left ventricular hypertrophy (LVH) is a predictor for cardiovascular mortality, and it is
considered to be a surrogate marker of preclinical cardiovascular disease. This study aimed …

Background. Vascular calcification is commonly found in chronic kidney disease (CKD)
patients and it is one of the predictors of cardiovascular death. Recently, several studies …

Background Complications associated with atherosclerosis in dialysis patients are attracting
attention. Fetuin-A, a circulating calcium-regulatory glycoprotein that inhibits vascular …

Background: Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis
(HD). An elevated incidence of cardiovascular calcifications (CVC) is observed in HD. Fetuin …

INTROduCTION Arterial thickening contributes to elevated cardiovascular risk in patients on
maintenance renal replacement therapy. The common carotid artery intima-media thickness …

Introduction: Chronic kidney disease (CKD) is an independent factor for cardiovascular
system complications, such as arterial hypertension, left ventricular hypertrophy (LVH), heart …